Dicofarm Polskasp. z o.o.
Wholesale of other food, including fish, crustaceans and molluscs
Overview
Dicofarm Polska belongs to the Italian Dicofarm group, which offers medicines, medical devices, food supplements and food for special medical purposes for children and adults. The company develops products through clinical research, certifications and cooperation with scientific advisers and universities; its portfolio includes electrolytes, butyrate, melatonin, cough, digestion, constipation, diarrhoea and reflux preparations, as well as probiotics.
Financials
Revenue history (in k)
Filing timeliness
Financial statements were filed on time, on average 63 days early. 2 of 6 audited by a statutory auditor.
- 202526/06/2026
- 202422/04/2025
- 202328/05/2024
- 202230/05/2023
- 202106/05/2022
- 202028/06/2021
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Industry
Offer
- Dietary supplements
- Medical devices
- Food for special medical purposes
- Electrolytes
- Probiotics
- Cough preparations
Website technology
- Online shop
- WooCommerce
- Website
- WordPress
- Elementor
Trademarks
Dicofarm Polska holds 1 active trademark registered with the Polish Patent Office. The first mark was filed in 2006.
| Mark | Number | Classes | Status | Protected until | |
|---|---|---|---|---|---|
| LBGG Lactobacillus Rhamnosus GG | Z.314427 | 3, 5, 29, 30, 32 | Protected | Aug 16, 2036 |
| Mark | Protected until | |
|---|---|---|
| LBGG Lactobacillus Rhamnosus GG | Aug 16, 2036 |
Authorized Representatives
Manner of representation
To make declarations of will on behalf of the company, joint action of two members of the management board is required. The President of the Management Board is authorised to independently represent the company.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Dicofarm Societa Per Azioni S.A. | 1,129 | $190,606.43 | 100% |
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2006-04-19.
43 1140 1010 0000 7257 2500 1002- 70 1140 1010 0000 7257 2500 1001
44 1240 1037 1111 0010 4187 0780
Debt
No entries in the National Debtors Register (KRZ).
MSiG notices
| Publication date | Event | |
|---|---|---|
| Apr 3, 2013 | Merger plan |
Public aid
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Jun 26, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $231.4K$231,401 | Polski Fundusz Rozwoju S.A. |
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
 BDO | BDO register entry | Active |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Unilever Polskasp. z o.o. | $634,564,941.96 | unilever.pl | ||
| Well Well InvestS.A. | $7,765,227.73 | well-well.eu | ||
| Foodpaksp. z o.o. | $3,778,871.78 | efoodpak.pl | ||
| Horeca Asian Foodsp. z o.o. | $3,744,072.12 | haf.com.pl | ||
| Miodowy Szlaksp. z o.o. | $2,305,119.53 | honey-way.com | ||
| Horeca Asian Food Wrocławsp. z o.o. | $1,135,719.91 | haf.com.pl | ||
| Genussp. z o.o. | $859,765.41 | genus.com.pl | ||
| NutrisleP.S.A. | $135,614.44 | nutrisle.com | ||
| Magellan Foodsp. z o.o. | $65,226.07 | magellanfood.eu | ||
| Ziarnexsp. z o.o. | $3,738.44 | ziarnex.pl |
Change history
| Date | Event | |
|---|---|---|
| 2025-03-03 | Name change ("vitis Pharma" → "dicofarm Polska") | |
| 2022-01-14 | Address change (Chmielna 85/87, 00-805, Warszawa → Giełdowa 7/9, 01-211, Warszawa) | |
| 2019-01-03 | Share capital increase (275,625.00 PLN → 705,625.00 PLN) | |
| 2015-04-23 | PKD change (Removed: 53 codes) | |
| 2014-09-18 | Share capital increase (273,750.00 PLN → 275,625.00 PLN) |
FAQ
Last updated: 2026-10-07